34 results
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
15 May 24
Pulse Biosciences Enhances Executive Leadership Team
9:05am
Exhibit 99.1
Pulse Biosciences Enhances Executive Leadership Team
Appoints proven atrial fibrillation medical technology leader Burke T. Barrett … Field Ablation™ (nsPFA™) technology (“Pulse”), today announced enhancements to its executive leadership team to support its next pivotal phase
8-K
EX-99.1
PLSE
Pulse Biosciences Inc
13 Nov 23
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
9:12am
Biosciences. “With the addition of another renowned cardiothoracic surgeon, Dr. Niv Ad, to our leadership team, we are on track to file a 510(k) submission
8-K
r0our1mfvnhf42x
12 Sep 23
Departure of Directors or Certain Officers
9:15am
8-K
EX-99.1
5bcn 3m2jlx5h
11 May 23
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
3taysa5czd3
1 May 23
Pulse Biosciences Announces $65 Million Private Placement
4:15pm
8-K
q2wnf1jdtd50e5 cqo
27 Sep 22
Departure of Directors or Certain Officers
5:42pm
8-K
EX-99.1
0g4eum7ts3mb0mrsa
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
8-K
z2bxsiftu2h
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm
8-K
EX-99.1
okv lai0h
11 May 22
Pulse Biosciences Reports First Quarter 2022 Financial Results
4:21pm